Cochrane · systematic review · CD010087
Prostaglandins before caesarean section for preventing neonatal respiratory distress
Motaze, NV, Mbuagbaw, L, Young, T · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
Pregnancy and ChildbirthAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 4 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Prostaglandin E2 Administered Before Caesarean Section for Prevention of Neonatal Respiratory Distress
Population: pregnant women at term.
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Respiratory distress Respiratory rate at rest > 60/min and/or signs of respiratory distress. | RR 0.33 | 1 study · 36 participants | Low Downgraded: imprecision |
Need for mechanical ventilation | no estimate extracted | 1 study · 36 participants | Low Downgraded: imprecision |
All cause fetal mortality | no estimate extracted | 1 study · 36 participants | Low Downgraded: imprecision |
Maternal adverse events | no estimate extracted | 1 study · 36 participants | Low Downgraded: imprecision |